Antimicrobial Resistance, Pharmacists, and Appreciative Inquiry: Development of a Novel Measurement Tool
Abstract
:1. Introduction
2. Results
2.1. Survey Tool Design and Development
- Section 1 contained 27 questions that asked about personal background, education, workplace location, and resource including antibiotic learning experience.
- Section 2 (the “Knowledge” domain) contained 15 statements, with three answer options to measure participants’ knowledge of the different aspects of antibiotic resistance, prescription and dispensing, epidemiology, and data relating to antibiotic use in Thailand. This section was developed from previously validated surveys used in Thailand and elsewhere [19,20,22,23,33,34,35,36,37].
- Section 3 (the “Attitude” domain) contained 17 questions with five-point Likert scale answer options for assessing participants’ attitudes that reflected the Discovery phase of AI theory.
- Section 4 contained 18 questions with five-point Likert scale answer options to assess participants’ vision of future antibiotic prescribing/dispensing in Thailand, which is reflected in the Dream phase of AI theory.
2.2. Translation and Back-Translation
2.3. Psychometric Validation
2.3.1. Face Validity
2.3.2. Content Validity
2.3.3. Reliability
2.4. Demographic of the Participants
2.5. Final Survey Tool
- Section 1, containing 24 questions that asked about personal background, education, workplace location, and resource including antibiotic learning experience.
- Section 2, or the “Knowledge” domain, containing 10 valid and reliable statements with three response options to measure participants’ knowledge of the different aspects of antibiotic resistance, prescription and dispensing, epidemiology, and data relating to antibiotic use in Thailand. This section was developed from previously validated surveys used in Thailand and elsewhere [19,20,22,23,33,34,35,36,37].
- Section 3, or the “Attitude” domain, containing 12 valid and reliable questions with five-point Likert scale answer options for assessing participants’ attitudes that reflected the Discovery phase of AI theory.
3. Discussion
3.1. Survey Tool Design and Development
3.2. Psychometric Validation
3.3. Limitations of the Study
3.3.1. Generalizability and Transferability of the Tool
3.3.2. Possible Measurement Bias as a Result of Applying AI Theory
3.3.3. Participant Recruitment Bias
4. Methods
4.1. Study Population and Survey Tool Administration
4.2. Survey Tool Design and Development
4.2.1. Hypothesis
4.2.2. Theoretical Framework
4.3. Psychometric Validation
4.3.1. Face Validity
4.3.2. Content Validity
4.3.3. Reliability Testing
4.4. Pilot Test
4.5. Translation and Back-Translation
4.6. Data Analysis
4.7. Ethics
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Appendix A
Use of Appreciative Inquiry Theory to Understand the Determinants of Antibiotic Smart Use amongst Community Pharmacies in Thailand. |
Demographic Section |
Please answer ALL questions as accurately as possible. |
Q1 At how many community pharmacies are you currently employed? |
⚬ None |
⚬ 1 |
⚬ 2 |
⚬ 3 |
⚬ Other (please specify) ________________________________________________ |
Skip To: End of Survey If Q1 = None |
Q2 Specifically referring to antibiotics, on average, how many antibiotics are dispensed by you at your community pharmacy, daily? |
⚬ Zero |
⚬ 1–25 |
⚬ 26–50 |
⚬ More than 50 |
Skip To: End of Survey If Q2 = None |
Q3 Of these antibiotics that are dispensed by you daily at your community pharmacy roughly, (Please manually put the percentage) |
_______ are oral (tablet, capsule, suspension) |
_______ are topical (cream, gel, ointment, paste, eye drop, ear drop) |
_______ are injectable |
_______ are other dosage forms |
Q4 Specifically referring to antibiotics, on average, how many are prescribed by you at your community pharmacy, daily? |
⚬ Zero |
⚬ 1–25 |
⚬ 26–50 |
⚬ More than 50 |
Display This Question: If Q4 ≠ Zero |
Q5 Of these antibiotics that are prescribed by you daily at your community pharmacy roughly, (Please manually put the percentage) |
_______ are oral (tablet, capsule, suspension) |
_______ are topical (cream, gel, ointment, paste, eye drop, ear drop) |
_______ are injectable |
_______ are other dosage forms |
Q6 What is/are the main reason(s) to patients/clients access antibiotics without prescription at your community pharmacy? (Please tick all that apply) |
▢ Lack of patient willingness to consult a physician for a non-serious infection |
▢ Inability to afford a consultation with a physician |
▢ Inability to travel to other clinics |
▢ Keeping leftover antibiotics for future use |
▢ Sharing antibiotics with others |
▢ Belief that antibiotics can speed up recovery |
▢ Belief that antibiotics can eradicate any infection |
▢ None of above |
▢ Other (please specify) ________________________________________ |
Q7 What is/are the main reason(s) for the pharmacist to prescribe antibiotics without prescription at your community pharmacy? (Please tick all that apply) |
▢ Demand by the manager |
▢ Demand by the owner |
▢ Demand by patients/clients |
▢ Patients/clients’ satisfaction |
▢ Fear of losing patients/clients |
▢ Sales offers and discounts by pharmaceutical companies |
▢ Increase sales/profit-seeking |
▢ Indicate possible infection with signs and symptoms |
▢ None of above |
▢ Other (please specify) ________________________________________ |
Q8 How do you describe the main community pharmacy at which you work? |
⚬ Independent store |
⚬ Chain store |
Q9 What is the postcode of your main community pharmacy at which you work? |
________________________________________________________________ |
Q10 How long have you been working as a community pharmacist? |
________________________________________________________________ |
Q11 What is your job title at the community pharmacy that you work at? (Please tick all that apply) |
▢ Owner |
▢ Manager |
▢ Staff pharmacist |
▢ Other (please specify) ________________________________________________ |
Q12 Do you have student internships in your community pharmacy? |
⚬ Yes |
⚬ No |
Q13 What is your name? |
(Optional, this answer will be identified the participants if they would like to withdraw by 90 days after completing the data collection.) |
________________________________________________________________ |
Q14 What is your gender? |
⚬ Male |
⚬ Female |
Q15 How old are you? |
⚬ Less than 30 |
⚬ 30–39 |
⚬ 40–49 |
⚬ 50–59 |
⚬ 60 and above |
Q16 What is/are the first qualifications in your professional degree? (You may choose more than one option) |
▢ BSc in Pharmacy |
▢ Doctor of Pharmacy: Pharm D (Pharmaceutical Care) |
▢ Doctor of Pharmacy: Pharm D (Industrial Pharmacy) |
▢ Doctor of Pharmacy: Pharm D (Pharmaceutical and Health Consumer Protection) |
▢ Doctor of Pharmacy: Pharm D (English programme) |
▢ Other pharmacy degree (please specific) __________________________ |
Q17 Which University did you graduate from for your undergraduate pharmacy degree? |
⚬ Chulalongkorn University |
⚬ Khon Kaen University |
⚬ Chiang Mai University |
⚬ Thammasat University |
⚬ Naresuan University |
⚬ Burapha University |
⚬ University of Phayao |
⚬ Payap University |
⚬ Mahasarakham University |
⚬ Mahidol University |
⚬ Rangsit University |
⚬ Walailak University |
⚬ Srinakharinwirot University |
⚬ Silpakorn University |
⚬ Prince of Songkla University |
⚬ Siam University |
⚬ Huachiew Chalermprakiet University |
⚬ Eastern Asia University |
⚬ Ubon Ratchathani University |
⚬ Other (please specify) ________________________________________________ |
Q18 What clerkships did you complete as part of your undergraduate pharmacy degree? (You may choose more than one option) |
▢ Community pharmacy |
▢ Hospital pharmacy |
▢ Manufacturing |
▢ Drug registration |
▢ Regulation and jurisdiction |
▢ Research and development |
▢ None of the above |
▢ Others (Please specify) |
Q19 How many years has it been since you first qualified as a pharmacist? |
⚬ Less than 1 |
⚬ 1 to 3 |
⚬ 4 or 10 |
⚬ 11 to 20 |
⚬ More than 20 |
Q20 Are you currently pursuing postgraduate qualification? |
⚬ Yes (Please state the name of the course) ______________________________________ |
⚬ No |
Q21 Have you had any training regarding antibiotic stewardship, during your pharmacy course? |
⚬ No |
⚬ Yes |
⚬ Cannot remember (Not sure) |
Q22 Have you had any training regarding antibiotic stewardship, since you have qualified as a pharmacist? |
⚬ No |
⚬ Yes, (how may courses) ________________________________________________ |
Q23 What sources do you use if you wish to refresh/update your knowledge of antibiotics? |
▢ Academic training session |
▢ Special literature |
▢ Patient information leaflet |
▢ Sales representative from pharmaceutical company |
▢ Articles in CCPE (left of continuing professional education) |
▢ Guidelines for the diagnosis and antibiotic treatments |
▢ Other (please specify) ________________________________________________ |
Q24 Besides working in community pharmacy, are you currently working as (Please tick all that apply) |
▢ Hospital Pharmacist |
▢ Pharmaceutical Sales and Marketing representative |
▢ Industrial Pharmacist |
▢ Teacher/Researcher in Academia/University |
▢ Researcher at Research and Development |
▢ Registration Pharmacist |
▢ Consumer Protection officer |
▢ Policy Maker |
▢ Antibiotic Smart Use/Antimicrobial Resistance Committee |
▢ None of the above (please specify) ______________________________________ |
Knowledge Domain |
Please answer only one option on each statement |
Q25 Dispensing antibiotics without a prescription is a legal practice in Thailand. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q26 Dispensing antibiotics without a prescription is a common practice among community pharmacists in Thailand. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q27 Dispensing antibiotics without a prescription is contributing to the development of antibiotic resistance. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q28 Dispensing antibiotics without a prescription is contributing to the inappropriate use of antibiotics by patients. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q29 Antibiotics are indicated to reduce any kind of pain and inflammation. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q30 Antibiotics are useful for bacterial infections. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q31 Antibiotics can cause secondary infections after killing the normal flora of the human body. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q32 Superbugs are microorganisms which generate antimicrobial resistance. They include bacteria, fungal, viruses or parasites. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q33 Resistance DNA in bacteria can transfer to other bacteria by a virus (bacteriophage). |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Q34 The main objective of antibiotic stewardship is the achievement of the most effective clinical outcome with the least adverse reactions. |
⚬ Yes |
⚬ No |
⚬ Don’t know |
Attitude Domain reflects Discovery Phase of Appreciative Inquiry |
Please answer these questions in relation to the common practices in your community pharmacy |
Q35 How do you rate the implementation of local guidelines such as Antibiotic Smart Use (ASU) by the Ministry of Health, before dispensing antibiotics? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q36 How do you rate the clarity of the advice given to the patients about their dispensed antibiotics? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q37 How do you rate the completeness of the advice given to the patients about their dispensed antibiotics? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q38 How do you rate the acknowledgment of the patients’ understanding of the advice given to them about their dispensed antibiotics? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q39 How do you rate the answering of patients’ questions about their dispensed antibiotics? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q40 How do you rate patients’ satisfaction with antibiotic dispensing? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q41 How do you rate the patients’ knowledge about antibiotic stewardship before counseling? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q42 How do you rate the Thai- FDA support to implement antibiotic stewardship in community pharmacy? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q43 How do you rate engagement with antibiotic awareness campaigns? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q44 How do you rate engagement with health promotion campaigns on prevention/reduction transmission of infection? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q45 How do you rate collaboration (such as referral) with other healthcare professionals to implement antibiotic stewardship? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Q46 How do you rate the relationship between clients/patients and pharmacists in regards with antibiotic stewardship? |
⚬ Very good |
⚬ Good |
⚬ Unsure |
⚬ Poor |
⚬ Very poor |
Thank you for taking the time to complete this questionnaire. |
References
- Heijden, M.V.D.; Sandgren, A.; Pränting, M.; Karvanen, M.; Aagaard, H.; Zorzet, A.; Ren, M.; Cars, O. ReAct–Action on Antibiotic. When the Drugs Don’t Work Antibiotic Resistance as a Global Development Problem; Dag Hammarskjöld Foundation Publisher: Uppsala, Sweden, 2019. [Google Scholar]
- World Bank. Drug-Resistant Infections: A Threat to Our Economic Future; World Bank: Washington, DC, USA, 2017. [Google Scholar]
- Interagency Coordination Group on Antimicrobial Resistance. No Time to Wait: Securing the Future from Drug-Resistant Infections Report to the Secretary-General of the United Nations; World Health Organization: Geneva, Switzerland, 2019. [Google Scholar]
- Aslam, B.; Wang, W.; Arshad, M.I.; Khurshid, M.; Muzammil, S.; Rasool, M.H.; Nisar, M.A.; Alvi, R.F.; Aslam, M.A.; Qamar, M.U.; et al. Antibiotic Resistance: A Rundown of a Global Crisis. Infect. Drug Resist. 2018, 11, 1645. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Centers for Disease Control, and Prevention. Antibiotic Resistance Threats in the United States. 2019. Available online: https://doi.org/10.15620/cdc:82532 (accessed on 29 April 2020).
- Cassini, A.; Diaz Högberg, L.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Skov Simonsen, G. Attributable Deaths and Disability-Adjusted Life-Years Caused by Infections with Antibiotic-Resistant Bacteria in the EU and the European Economic Area in 2015: A Population-Level Modelling Analysis. Lancet Infect. Dis. 2019, 19, 56–66. [Google Scholar] [CrossRef] [Green Version]
- Kumarasamy MPhil, K.K.; Krishnan, P.; Toleman, M.A.; Walsh, T.R.; Bagaria, J.; Balakrishnan, R.; Doumith, M.; Maharjan, S.; Mushtaq, S.; Noorie, T.; et al. Emergence of a New Antibiotic Resistance Mechanism in India, Pakistan, and the UK: A Molecular, Biological, and Epidemiological Study. Lancet Infect. Dis. 2010, 10, 597–602. [Google Scholar] [CrossRef]
- Laxminarayan, R.; Duse, A.; Wattal, C.; Zaidi, A.K.; L Wertheim, H.F.; Sumpradit, N.; Vlieghe, E.; Levy Hara, G.; Gould, I.M.; Goossens, H.; et al. The Lancet Infectious Diseases Commission Antibiotic Resistance-the Need for Global Solutions Part 1: Global Epidemiology of Antibiotic Resistance and Use. Lancet Infect. Dis. 2013. [Google Scholar] [CrossRef] [Green Version]
- Morgan, D.J.; Okeke, I.N.; Laxminarayan, R.; Perencevich, E.N.; Weisenberg, S. Non-Prescription Antimicrobial Use Worldwide: A Systematic Review. Lancet Infect. Dis. 2011, 11, 692–701. [Google Scholar] [CrossRef] [Green Version]
- Chereau, F.; Opatowski, L.; Tourdjman, M.; Vong, S. Risk Assessment for Antibiotic Resistance in South East Asia. BMJ 2017, 358, 2–8. [Google Scholar] [CrossRef] [Green Version]
- Holloway, K.A.; Kotwani, A.; Batmanabane, G.; Puri, M.; Tisocki, K. Antibiotic Use in South East Asia and Policies to Promote Appropriate Use: Reports from Country Situational Analyses. BMJ 2017, 358, 9–13. [Google Scholar] [CrossRef] [Green Version]
- Sommanustweechai, A.; Tangcharoensathien, V.; Malathum, K.; Sumpradit, N.; Kiatying-Angsulee, N.; Janejai, N.; Jaroenpoj, S. Implementing National Strategies on Antimicrobial Resistance in Thailand: Potential Challenges and Solutions. Public Health 2018, 157, 142–146. [Google Scholar] [CrossRef]
- Sommanustweechai, A.; Chanvatik, S.; Sermsinsiri, V.; Sivilaikul, S.; Patcharanarumol, W.; Yeung, S.; Tangcharoensathien, V. Antibiotic Distribution Channels in Thailand: Results of Key-Informant Interviews, Reviews of Drug Regulations and Database Searches. Bull. World Health Organ. 2018, 96, 101–109. [Google Scholar] [CrossRef]
- Khamsarn, S.; Nampoonsak, Y.; Busamaro, S.; Tangkoskul, T.; Seenama, C.; Rattanaumpawan, P.; Boonyasiri, A.; Thamlikitkul, V. Epidemiology of Antibiotic Use and Antimicrobial Resistance in Selected Communities in Thailand. J. Med. Assoc. Thail. 2016, 99, 270–275. [Google Scholar]
- Panumart, P.; Phodha, T.; Thamlikitkul, V.; Riewpaiboon, A.; Prakongsai, P.; Limwattananon, S. Health and Economic Impacts of Antimicrobial Resistant Infections in Thailand: A Preliminary Study. J. Health Syst. Res. 2012, 6, 352–360. [Google Scholar] [CrossRef]
- Sumpradit, N.; Chongtrakul, P.; Anuwong, K.; Pumtong, S.; Kongsomboon, K.; Butdeemee, P.; Khonglormyati, J.; Chomyong, S.; Tongyoung, P.; Losiriwat, S.; et al. Antibiotics Smart Use: A Workable Model for Promoting the Rational Use of Medicines in Thailand. Bull. World Health Organ. 2012, 90, 905–913. [Google Scholar] [CrossRef] [PubMed]
- Bureau of Drug Control. Drug Statistic. Available online: https://www.fda.moph.go.th/sites/drug/Shared Documents/Statistic/Licensee-20190828.pdf (accessed on 29 October 2020).
- Saramunee, K.; Chaiyasong, S.; Krska, J. View of Public Health Roles for Community Pharmacy: Contrasts and Similarities between England and Thailand. Isan J. Pharm. Sci. 2011, 7, 1–11. [Google Scholar]
- Hadi, M.A.; Karami, N.A.; Al-Muwalid, A.S.; Al-Otabi, A.; Al-Subahi, E.; Bamomen, A.; Mohamed, M.M.A.; Elrggal, M.E. Community Pharmacists’ Knowledge, Attitude, and Practices towards Dispensing Antibiotics without Prescription (DAwP): A Cross-Sectional Survey in Makkah Province, Saudi Arabia. Int. J. Infect. Dis. 2016, 47, 95–100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mansour, O.; Al-Kayali, R. Community Pharmacists' Role in Controlling Bacterial Antibiotic Resistance in Aleppo, Syria. Iran. J. Pharm. Res. 2017, 16, 1612–1620. [Google Scholar]
- Mahmoud, M.A.; Aldhaeefi, M.; Sheikh, A.; Aljadhey, H. Community Pharmacists Perspectives about Reasons behind Antibiotics Dispensing without Prescription: A Qualitative Study. Biomed. Res. 2018, 29, 3792–3796. [Google Scholar] [CrossRef] [Green Version]
- Jamshed, S.; Padzil, F.; Shamsudin, S.; Bux, S.; Jamaluddin, A.; Bhagavathula, A.; Azhar, S.; Hassali, M. Antibiotic Stewardship in Community Pharmacies: A Scoping Review. Pharmacy 2018, 6, 92. [Google Scholar] [CrossRef] [Green Version]
- Siltrakool, B. Assessment of Community Pharmacists’ Knowledge, Attitude and Practice Regarding Non-Prescription Antimicrobial Use and Resistance in Thailand. Master’s Thesis, University of Hertfordshire, Hatfield, UK, 2017. Unpublished. [Google Scholar]
- Richer, M.-C.; Ritchie, J.; Marchionni, C. Appreciative Inquiry in Health Care. Br. J. Healthc. Manag. 2010, 16, 164–172. [Google Scholar] [CrossRef]
- Trevitt Scott, J.; Cheryl Armstrong, A. Disrupting the Deficit Discourse: Reframing Metaphors for Professional Learning in the Context of Appreciative Inquiry. Prof. Dev. Educ. 2018, 45, 114–124. [Google Scholar] [CrossRef]
- Hung, L. Using Appreciative Inquiry to Research Practice Development. Int. Pract. Dev. J. 2017, 7, 1–7. [Google Scholar] [CrossRef]
- Watkins, S.; Dewar, B.; Kennedy, C. Appreciative Inquiry as an Intervention to Change Nursing Practice in In-Patient Settings: An Integrative Review. Int. J. Nurs. Stud. 2016, 60, 179–190. [Google Scholar] [CrossRef] [Green Version]
- Du Toit, S.H.J.; Buchanan, H. Embracing Cultural Diversity: Meaningful Engagement for Older Adults with Advanced Dementia in a Residential Care Setting. Am. J. Occup. Ther. 2018, 72, 7206205090. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Carter, C.A.; Ruhe, M.C.; Weyer, S.; Litaker, D.; Fry, R.E.; Stange, K.C. An Appreciative Inquiry Approach to Practice. Qual. Manag. Healthc. 2007, 16, 194–204. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cooperrider, D.L.; Whitney, D.K.; Stavros, J.M. Appreciative Inquiry Handbook: For Leaders of Change, 2nd ed.; Berrett-Koehler Publishers: San Francisco, CA, USA, 2008. [Google Scholar]
- Whitney, D.K.; Trosten-Bloom, A. The Power of Appreciative Inquiry: A Practical Guide to Positive Change; Berrett-Koehler Publishers: San Francisco, CA, USA, 2010. [Google Scholar]
- Aslam, A.; Gajdács, M.; Zin, C.S.; Rahman, N.S.B.A.; Ahmed, S.I.; Jamshed, S.Q. Public Awareness and Practices towards Self-Medication with Antibiotics among the Malaysian Population. A Development of Questionnaire and Pilot-Testing. Antibiotics 2020, 9, 97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- López-Vázquez, P.; Vázquez-Lago, J.M.; Gonzalez-Gonzalez, C.; Piñeiro-Lamas, M.; López-Durán, A.; Herdeiro, M.T.; Figueiras, A.; Caamaño-Isorna, F.; Gestal-Otero, J.J.; Taracido, M.; et al. Development and Validation of the Knowledge and Attitudes Regarding Antibiotics and Resistance (KAAR-11) Questionnaire for Primary Care Physicians. J. Antimicrob. Chemother. 2016, 71, 2972–2979. [Google Scholar] [CrossRef] [PubMed]
- Truter, I.; Knoesen, B.C. Perceptions towards the Prescribing of Antibiotics by Pharmacists and the Use of Antibiotics in Primary Care in South Africa. J. Infect. Dev. Ctries. 2018, 12, 115–119. [Google Scholar] [CrossRef]
- Hardy-Holbrook, R.; Aristidi, S.; Chandnani, V.; Dewindt, D.; Dinh, K. Antibiotic Resistance and Prescribing in Australia: Current Attitudes and Practice of GPs. Healthc. Infect. 2013, 18, 147–151. [Google Scholar] [CrossRef] [Green Version]
- Sarwar, M.R.; Saqib, A.; Iftikhar, S.; Sadiq, T. Knowledge of Community Pharmacists about Antibiotics, and Their Perceptions and Practices Regarding Antimicrobial Stewardship: A Cross-Sectional Study in Punjab, Pakistan. Infect. Drug Resist. 2018, 11, 133–145. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Roque, F.; Soares, S.; Breitenfeld, L.; Figueiras, A.; Herdeiro, M.T. Influence of Community Pharmacists’ Attitudes on Antibiotic Dispensing Behavior: A Cross-Sectional Study in Portugal. Clin. Ther. 2015, 37, 168–177. [Google Scholar] [CrossRef]
- Devon, H.A.; Block, M.E.; Moyle-Wright, P.; Ernst, D.M.; Hayden, S.J.; Lazzara, D.J.; Savoy, S.M.; Kostas-Polston, E. A Psychometric Toolbox for Testing Validity and Reliability. J. Nurs. Scholarsh. 2007, 39, 155–164. [Google Scholar] [CrossRef]
- Jasovsk, D.; Littmann, J.; Zorzet, A.; Cars, O. Antimicrobial Resistance-a Threat to the World’s Sustainable Development. Ups. J. Med. Sci. 2016, 121, 159–164. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rizvi, T.; Thompson, A.; Williams, M.; Zaidi, S.T.R. Validation and Implementation of a National Survey to Assess Antimicrobial Stewardship Awareness, Practices and Perceptions amongst Community Pharmacists in Australia. J. Glob. Antimicrob. Resist. 2020, 21, 28–33. [Google Scholar] [CrossRef] [PubMed]
- Taber, K.S. The Use of Cronbach’s Alpha When Developing and Reporting Research Instruments in Science Education. Res. Sci. Educ. 2018, 48, 1273–1296. [Google Scholar] [CrossRef]
- Whitaker, C.; Stevelink, S.; Fear, N. The Use of Facebook in Recruiting Participants for Health Research Purposes: A Systematic Review. J. Med. Internet Res. 2017, 19, e290. [Google Scholar] [CrossRef] [Green Version]
- Thailand: Social Media Penetration 2018|Statista. Available online: https://www.statista.com/statistics/284483/thailand-social-network-penetration/ (accessed on 2 October 2020).
- The Royal Thai Government. Drug Act B.E. 1967. Available online: https://www.fda.moph.go.th/sites/logistics/Thelaws_Document/Drugs%20Act,%20B.E.%202510%20(1967)/DRUGSB.E.2510.pdf (accessed on 6 August 2019).
- Yotsombut, K.; Pengsuparp, T.; Palapinyo, S. Community Pharmacy Practice in Thailand: The Diversity of Practice. Res. Soc. Adm. Pharm. 2012, 8, e9–e10. [Google Scholar] [CrossRef]
- Chover-Sierra, E.; Martínez-Sabater, A. Utility of Social Networks and Online Data Collection in Nursing Research: Analysis of Spanish Nurses’ Level of Knowledge about Palliative Care. PLoS ONE 2018, 13, e0197377. [Google Scholar] [CrossRef] [Green Version]
- Alumran, A.; Hou, X.Y.; Hurst, C. Validity and Reliability of Instruments Designed to Measure Factors Influencing the Overuse of Antibiotics. J. Infect. Public Health 2012, 5, 221–232. [Google Scholar] [CrossRef] [Green Version]
- Wienclaw, R.A. Validity; Salem Press Encyclopedia: Amenia, NY, USA, 2019. [Google Scholar]
- Berberoglu, G.; Hei, L.M. Indexes of Item-Objective Congruence for Multidimensional Items. Int. J. Test. 2003, 3, 173. [Google Scholar] [CrossRef]
- Sidani, S.; Guruge, S.; Miranda, J.; Ford-Gilboe, M.; Varcoe, C. Cultural Adaptation and Translation of Measures: An Integrated Method. Res. Nurs. Health 2010, 33, 133–143. [Google Scholar] [CrossRef]
- Using and Interpreting Cronbach’s Alpha|University of Virginia Library Research Data Services + Sciences. Available online: https://data.library.virginia.edu/using-and-interpreting-cronbachs-alpha/ (accessed on 12 April 2020).
- Bland, J.M.; Altman, D. Statistics Notes Cronbach’s Alpha. BMJ 1997, 314, 572. [Google Scholar] [CrossRef] [Green Version]
- Bai, Y.; Li, J.; Bai, Y.; Ma, W.; Yang, X.; Ma, F. Development and Validation of a Questionnaire to Evaluate the Factors Influencing Training Transfer among Nursing Professionals. BMC Health Serv. Res. 2018, 18, 107. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Bujang, M.A.; Omar, E.D.; Baharum, N.A. A Review on Sample Size Determination for Cronbach’s Alpha Test: A Simple Guide for Researchers. Malays. J. Med. Sci. 2018, 25, 85–99. [Google Scholar] [CrossRef] [PubMed]
- Revelle, W. Psych: Procedures for Psychological, Psychometric, and Personality Research; Northwestern University: Evanston, IL, USA, 2019. [Google Scholar]
- RStudio Team. RStudio: Integrated Development for R. RStudio; RStudio, PBC: Boston, MA, USA, 2020; Available online: http://www.rstudio.com/ (accessed on 10 October 2020).
Question/Statement | Psychometric Validation | ||
---|---|---|---|
Face Validation | Content Validation (IOC Index 1) | Reliability Testing | |
Knowledge Section | 0.64 | ||
Dispensing antibiotics without a prescription is a legal practice in Thailand. | Accept | 1 | |
Dispensing antibiotics without a prescription is a common practice among community pharmacists in Thailand. | Accept | 0.67 | |
Dispensing antibiotics without a prescription is contributing to the development of antibiotic resistance. | Accept | 0.67 | |
Dispensing antibiotics without a prescription is contributing to the inappropriate use of antibiotics by patients. | Accept | 0.67 | |
Antibiotic resistance has become a public health issue. | Accept | 1 | Exclude |
Antibiotics are indicated to reduce any kind of pain and inflammation. | Accept | 0.67 | |
Antibiotics are useful for bacterial infections. | Accept | 0.67 | |
Antibiotics are useful for viral infections. | Reject | ||
Antibiotics can cause secondary infections after killing the normal flora of the human body. | Accept | 1 | |
Antibiotics can cause allergic reactions. | Reject | - | |
One should stop taking antibiotics before the completion of a full course of antibiotic therapy, if symptoms improve. | Reject | - | |
Misuse of antibiotics can lead to a loss of susceptibility of a specific pathogen to an antibiotic. | Accept | 1 | Exclude |
Superbugs are microorganisms which generate antimicrobial resistance. They include bacteria, fungal, viruses or parasites. | Accept | 1 | |
Resistance DNA in bacteria can transfer to other bacteria by a virus. | Accept | 1 | |
The main objective of antibiotic stewardship is the achievement of the most effective clinical outcome with the least adverse reactions. | Accept | 1 |
Question/Statement | Psychometric Validation | ||
---|---|---|---|
Face Validation | Content Validation (IOC Index 1) | Reliability Testing | |
Discovery | 0.84 | ||
How do you rate the implementation of local guidelines, before dispensing antibiotics? | Accept | 1 | |
How do you rate the implementation of local guidelines, before prescribing antibiotics? | Reject | - | |
How do you rate the clarity of the advice given to the patients about their dispensed antibiotics? | Accept | 1 | |
How do you rate the completeness of the advice given to the patients about their dispensed antibiotics? | Accept | 0.67 | |
How do you rate the acknowledgment of the patients’ understanding of the advice given to them about their dispensed antibiotics? | Accept | 1 | |
How do you rate the answering of patients’ questions about their dispensed antibiotics? | Accept | 0.67 | |
How do you rate the manager’s understanding of antibiotic stewardship? | Reject | - | |
How do you rate the owner’s understanding of antibiotic stewardship? | Reject | - | |
How do you rate patients’ satisfaction with antibiotic dispensing? | Accept | 0.67 | |
How do you rate patients’ satisfaction with your antibiotic prescribing practices? | Reject | - | |
How do you rate the patients’ knowledge about antibiotic stewardship? | Accept | 0.67 | |
How do you rate antibiotic inventory management? | Reject | - | |
How do you rate the support to implement antibiotic stewardship? | Accept | 1 | |
How do you rate engagement with antibiotic awareness campaigns? | Accept | 1 | |
How do you rate engagement with health promotion campaigns on prevention/reduction transmission of infection? | Accept | 1 | |
How do you rate collaboration with other healthcare professionals to implement antibiotic stewardship? | Accept | 1 | |
How do you rate the relationship between clients/patients and pharmacists in regards with antibiotic stewardship? | Accept | 0.67 |
Characteristics | n = 373 (%) |
---|---|
Gender and Age | |
Male | 128 (34.32) |
Less than 30 | 48 (12.87) |
30–39 | 49 (13.14) |
40–49 | 16 (4.29) |
50–59 | 10 (2.68) |
60 and above | 5 (1.34) |
Female | 245 (65.68) |
Less than 30 | 108 (28.95) |
30–39 | 107 (28.69) |
40–49 | 25 (6.70) |
50–59 | 3 (0.80) |
60 and above | 2 (0.54) |
Postgraduate qualification | |
Yes | 66 (17.69) |
No | 307 (82.31) |
Location in Thailand | |
Northern | 21 (5.63%) |
Northeastern (Isan) | 113 (30.29%) |
Western | 5 (1.34%) |
Central | 144 (38.61%) |
Eastern | 37 (9.92%) |
Southern | 37 (9.92%) |
Characteristics | n = 373 (%) |
---|---|
Pharmacy University | |
Burapha University | 5 (1.34) |
Chiang Mai University | 28 (7.51) |
Chulalongkorn University | 25 (6.70) |
Eastern Asia University | 4 (1.07) |
Huachiew Chalermprakiet University | 18 (4.83) |
Khon Kaen University | 28 (7.51) |
Mahasarakham University | 17 (4.56) |
Mahidol University | 20 (5.36) |
Naresuan University | 20 (5.31) |
Payap University | 5 (1.34) |
Prince of Songkla University | 14 (3.75) |
Rangsit University | 31 (8.31) |
Siam University | 5 (1.34) |
Silpakorn University | 28 (7.51) |
Srinakharinwirot University | 10 (2.68) |
Ubon Ratchathani University | 97 (26.01) |
University of Phayao | 7 (1.88) |
Walailak University | 7 (1.88) |
University outside Thailand | 4 (1.07) |
Undergraduate degree | |
BSc in Pharmacy | 196 (52.55) |
BSc in Pharmacy and Doctor of Pharmacy: Pharm D (Pharmaceutical Care) | 10 (2.86) |
BSc in Pharmacy: Pharm D (Industrial Pharmacy) | 3 (0.80) |
BSc in Pharmacy, Doctor of Pharmacy: Pharm D (Pharmaceutical and Health Consumer Protection) | 1 (0.27) |
Doctor of Pharmacy: Pharm D (Pharmaceutical Care) | 134 (35.92) |
Doctor of Pharmacy: Pharm D (Pharmaceutical Care) and Doctor of Pharmacy: Pharm D (Industrial Pharmacy) | 1 (2.68) |
Doctor of Pharmacy: Pharm D (Pharmaceutical Care) and Doctor of Pharmacy: Pharm D (English Program) | 1 (2.68) |
Doctor of Pharmacy: Pharm D (Industrial Pharmacy) | 25 (6.70) |
Doctor of Pharmacy: Pharm D (Pharmaceutical and Health Consumer Protection) | 1 (2.68) |
Doctor of Pharmacy: Pharm D (English Program) | 1 (2.68) |
Clerkship a | |
Community pharmacy | 319 |
Hospital pharmacy | 308 |
Manufacturing | 100 |
Drug registration | 28 |
Regulation and jurisdiction | 25 |
Research and development | 53 |
Other | 22 |
Characteristics | n = 373 (%) |
---|---|
Experience as community pharmacist (years) | |
Mean | 5.65 |
Median | 3 |
Role in community pharmacy | |
Owner | 29 (7.77) |
Owner, manager and staff pharmacist | 32 (8.58) |
Owner and staff pharmacist | 76 (20.38) |
Manager | 4 (1.07) |
Manager and staff pharmacist | 32 (8.58) |
Staff pharmacist | 200 (53.62) |
Additional Role a | |
Hospital pharmacist | 150 |
Pharmaceutical sales and marketing representative | 28 |
Industrial pharmacist | 17 |
Teacher/research in academia/university | 24 |
Researcher at research and development | 6 |
Registration pharmacist | 15 |
Consumer protection officer | 28 |
Policy maker | 1 |
Antibiotic smart use/antimicrobial resistance committee | 1 |
Community pharmacy (only) | 130 |
Other | 5 |
Type of pharmacy | |
Independent store | 247 (66.22) |
Chain store | 126 (33.78) |
Characteristics | n = 373 (%) |
---|---|
Reasons to patients/client access antibiotics without prescription a | |
Lack of patient willingness to consult a physician for a non-serious infection | 299 |
Inability to afford a consultation with a physician | 113 |
Inability to travel to other clinics | 128 |
Keeping leftover antibiotics for future use | 139 |
Sharing antibiotics with others | 19 |
Belief that antibiotics can speed up recovery | 185 |
Belief that antibiotics can eradicate any infection | 124 |
Other | 18 |
Reason for pharmacist to prescribe antibiotics without prescription a | |
Demand by the manager | 16 |
Demand by the owner | 24 |
Demand by patients/clients | 176 |
Patients/clients’ satisfaction | 86 |
Fear of losing patients/clients | 33 |
Sales offers and discounts by pharmaceutical companies | 4 |
Increase sales/profit-seeking | 19 |
Indicate possible infection with signs and symptoms | 329 |
Other | 4 |
Characteristics | n = 373 (%) |
---|---|
Antibiotic stewardship training experience | |
During pharmacy course | |
No | 94 (25.20) |
Yes | 202 (54.16) |
Not sure | 77 (20.64) |
Since pharmacy degree qualified | |
No | 258 (69.17) |
Yes | 115 (30.83) |
Sources of knowledge a | |
Training session | 265 |
Special literature | 237 |
Patient information leaflet | 134 |
Sales representative from pharmaceutical company | 104 |
Articles in CCPE (center of continuing professional education) | 273 |
Guidelines for the diagnosis and antibiotic treatments | 249 |
Other | 9 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Netthong, R.; Ahmadi, K.; Kane, R. Antimicrobial Resistance, Pharmacists, and Appreciative Inquiry: Development of a Novel Measurement Tool. Antibiotics 2020, 9, 798. https://doi.org/10.3390/antibiotics9110798
Netthong R, Ahmadi K, Kane R. Antimicrobial Resistance, Pharmacists, and Appreciative Inquiry: Development of a Novel Measurement Tool. Antibiotics. 2020; 9(11):798. https://doi.org/10.3390/antibiotics9110798
Chicago/Turabian StyleNetthong, Rojjares, Keivan Ahmadi, and Ros Kane. 2020. "Antimicrobial Resistance, Pharmacists, and Appreciative Inquiry: Development of a Novel Measurement Tool" Antibiotics 9, no. 11: 798. https://doi.org/10.3390/antibiotics9110798
APA StyleNetthong, R., Ahmadi, K., & Kane, R. (2020). Antimicrobial Resistance, Pharmacists, and Appreciative Inquiry: Development of a Novel Measurement Tool. Antibiotics, 9(11), 798. https://doi.org/10.3390/antibiotics9110798